Co-expression of TNFα and IL-1β in human acute pulmonary fibrotic diseases: An immunohistochemical analysis

Pathology International

Volumn 46, Issue 2, 1996, Pages 91-99

  Pan, Li Hua ^a   Ohtani, Haruo ^a   Yamauchi, Kohei ^a,b   Nagura, Hiroshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

fibrotic lung diseases; immunohistochemistry; interleukin 1 (IL 1); tumor necrosis factor (TNF )

Indexed keywords

INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; MALE; PRIORITY JOURNAL;

EID: 0029952585     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1996.tb03584.x     Document Type: Article

References (30)

1. Richards RJ, Masek LC, Brown RF. Biochemical and cellular mechanisms of pulmonary fibrosis. Toxicol. Pathol. 1991; 19: 526-539.
2. Dunnill MS. Pulmonary fibrosis. Histopathology 1990; 16: 321-329.
3. McGee JO'D, Isaacson PG, Wright NA. Oxford Textbook of Pathology. Vol. 2a. Pathology of systems, Oxford University Press, Oxford, 1992.
4. Fukuda Y, Ishizaki M, Masda Y, Kimura G, Kawanami O, Masugi Y. The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am. J. Pathol. 1987; 126: 171-182.
5. Yamaguchi M, Takahashi T, Togasshi H, Arai H, Motomiya M. The corrected collagen content in paraquat lungs. Chest 1986; 90: 251-257.
6. Piguet PF, Grau GE, Vassalli P. Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis. Am. J. Pathol. 1990; 136: 103-110.
7. Zhang Y, Lee TC, Guillemin B, Yu M, Rom WN. Enhanced IL-1β and tumor necrosis factor-α release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J. Immunol. 1993; 150: 4188-4196.
8. Nash JRG, McLaughlin PL, Hoyle C, Roberts D. Immunolocalization of tumor necrosis factor α in lung tissue from patients dying with adult respiratory distress syndrome. Histopathology 1991; 19: 395-402.
9. Kelly J. Cytokine of the lung. Am. Rev. Respir. Dis. 1990; 141: 765-788.
10. Piguet PF, Ribaux C, Karpuz V, Grau GE, Kapanci Y. Expression and localization of tumor necrosis factor-α and its mRNA in idiopathic pulmonary fibrosis. Am. J. Pathol. 1993; 143: 651-655.
11. Oppenheim JJ, Kovacs EJ, Matsushima K, Durum SK. There is more than one interleukin 1. Immunol. Today 1986; 7: 45-46.
12. Lamontage L, Gauldie J, Stadnyk A, Richards C, Jenkins E. In vivo initiation of unstimulated in vitro interleukin-1 release by alveolar macrophages. Am. Rev. Respir. Dis. 1985; 131: 326-330.
13. Weissler JC, Lyons CR, Lipscomb MF, Towes GB. Human pulmonary macrophages. Functional comparison of cells obtained from whole lung and by bronchoalveolar lavage. Am. Rev. Respir. Dis. 1986; 133: 473-477.
14. Kuhn III C, Boldt J, King TE, Crouch E, Vartio T, McDonald JA. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am. Rev. Respir. Dis. 1989; 140: 1693-1703.
15. Tracey KJ, Beutler B, Lowry SF et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470-474.
16. Remick DG, Kunked AG, Larrick JW, Kunkel SL. Acute in vivo effects of recombinant tumor necrosis factor. Lab. Invest. 1987; 56: 587-590.
17. Le J, Vilcek J. Tumor necrosis factor and interleukin 1: Cytokines with multiple overlapping biological activities. Lab. Invest. 1987; 56: 234-248.
18. Goldbulm SE, Hennig B, Jay M, Yoneda K, McClain CJ. Tumor necrosis factor alpha-induced pulmonary vascular endothelial injury. Infect. Immund. 1989; 57: 1218-1226.
19. Stephens KE, Ishizaka A, Larrick JW, Raffin TA. Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury. Am. Rev. Respir. Dis. 1988; 137: 1364-1370.
20. Warren JS, Yabroff KR, Remick DG et al. Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J. Clin. Invest. 1989; 84: 1873-1882.
21. Ferrari-Baliviera E, Mealy K, Smith RJ, Wilmore DW. Tumor necrosis factor induces adult respiratory syndrome in rats. Arch. Surg. 1989; 124: 1400-1405.
22. Stanley MW, Henry-Stanley MJ, Gajl-Peczalska KJ, Bitterman PB. Hyperplasia of type II pneumocytes in acute lung injury. Am. J. Clin. Pathol. 1992; 97: 669-677.
23. Sumi Y, Nagura H, Takeuchi M, Miyakawa M. Granulomatous lesions in the lung induced by inhalation of mold spores. Virchows Arch. 1994; 424: 661-668.
24. Last JA, Siefkin AD, Reiser KM. Type I collagen content is increased in lungs of patients with adult respiratory distress syndrome. Thorax 1983; 38: 364-368.
25. Reiser KM, Last JA. Pulmonary fibrosis in experimental acute respiratory disease. Am. Rev. Respir. Dis. 1981; 123: 58-63.
26. March CJ, Mosley B, Larsen A et al. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 1985; 315: 641-645.
27. Nawroth PP, Bank I, Handley D, Cassimeris J, Chess L, Stern D. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J. Exp. Med. 1986; 163: 1363-1375.
28. Kohase M, May LT, Tamm I, Vilcek J, Sehgal PB. A cytokine network in human diploid fibroblasts interactions of beta-interferons, tumor necrosis factor, platlet-derived growth factor and interleukin-1. Mol. Cell. Biol. 1987; 7: 273-280.
29. Vilcek J, Tsujimoto M, Palombella VJ, Kohase M, Le J. Tumour necrosis factor: Receptor binding and mitogenic action in fibroblasts. J. Cell Physiol. 1987; 5 (Suppl.): 57-61.
30. Lazenby AJ, Crouch EC, McDonald JA, Kuhn III C. Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat. Am. Rev. Respir. Dis. 1990; 142: 206-214.